Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd. is a company headquartered in Songjiang, China. The firm provides cancer treatment services.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Guangdong Zhaotai In vivo Biomedical Technology Co., Ltd., established on 2016-04-05, Business scope includes biomedical technology research;Medical Research and Experimental Development;Biotechnology Development Services;Biotechnology Transfer Services;Biotechnology Consulting,communication service;Human Science Research Achievement Transfer Service;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Import and export(Excluding franchised products);Technology Import and Export;

Vycellix, Inc. is an American private company located in Tampa, FL. The firm operates as a biopharmaceutical company. Evren Alici is currently the CEO of the firm.\nThe company says this about itself: Vycellix is a private, immuno-centric discovery life science company, advancing the development of transformational platform technologies to enhance and optimize next-generation cell & gene-based therapies, including T cell and natural killer (NK) cell-based cancer therapies.

Cofactor Genomics is a Predictive Immune Modeling company driven to remove the barriers that have prohibited the advancement of true precision medicine. Cofactor is enabling the industry to move beyond isolated, single-analyte biomarkers to powerful multidimensional biomarkers using Health Expression Models. Through their molecular, informatic, and database tools, and one of the first CAP-certified, clinical RNA sequencing laboratories, Cofactor enables their partners to deliver more expedient, cost-effective, and successful clinical trials.

Electrophoretics Ltd., a subsidiary of Proteome Sciences Plc, is a British company located in London. The firm engages in research and experimental development on natural sciences. It was founded in 1992.

Chongqing Precision Biotechnology Co., Ltd. is a private company headquartered in Chongqing, China, that provides research and development biotechnology services.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

MicroMedMark develops basic research, applied basic research, transformation research, and a biomedical technology enterprise for industrial transformation. Their products and services include a pancreatic cancer detection kit, a detection kit product pipeline, and nucleic acid.

Huaxia Yuan Cell Engineering Group Co., Ltd., established on 2015-10-26, Business scope includes general items:Engaged in tissue and cell storage,cell preparation,Technical services for human genetic diagnosis and treatment,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals),Human stem cell technology development and application,Medical Research and Experimental Development,Engineering and Technology Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Yachen Intelligent Bioengineering Co., Ltd., established on 2015-11-04, Business scope includes general business items:Technology R&D in Bioengineering;Technology development of biomedicine,Technical Services,technical consulting,Achievement transfer;Technical development and technical consultation of medical devices;account Serive;Conference Consulting,Conference and exhibition,Enterprise Marketing Planning;Sales of agricultural and sideline products(Does not contain grain,food);Import and export business;e-commerce.,The licensing program is:biological antibody preparation;anti-(suppress)Bacterial preparation(suppositories,except soap)gel,liquid,ointment,purify,sanitary napkin,Production and sales of sanitary wipes;Biological product,medicine,one type,Class II,Three types of medical device research and development,Production,Sales;Healthy food,cosmetic,Daily Chemicals,Sales of cleaning products,Disinfection supplies,Cleaning Products,daily necessities,personal care products,;chemical preparation,Biological product,various medicines,Healthy food,Research and development of sanitary materials and medical supplies,Production,Sales;animal medicine,Livestock farming,feed,Research and development of feed additives,production and sales.

Daegu Gyeongbuk Institute of Science and Technology (DGIST) (In Korean 대구경북과학기술원) is a public science and engineering university located in Daegu Metropolitan City, Republic of Korea. Under a Special Act on Support of Scientists and Engineers for Strengthening National Science and Technology Competitiveness, the Korean government enacted Daegu Gyeongbuk Institute of Science and Technology Act (Act No. 6996) and founded DGIST in 2004 as a research institute. In 2008, the act was amended to extend the role of the institute to both research and education, which eventually enabled a transition from a research institute to a university.

Shanghai Cell Therapy Group Co. Ltd. is a Chinese company located in Shanghai that operates as a cell therapy company. The firm was founded in 2013 by Jie Wei Li.\nThe company says this about itself: Founded in 2013, Shanghai Cell Therapeutics Group Co., Ltd is located at the Shanghai Municipal Engineering and Technology Research Center, which was established by the Shanghai Science and Technology Commission. With a mission of \"changing the length and abundance of life with cell therapy\", SHCell has created a closed-loop industrial chain and an integrated platform for cell treatment and cell therapy. It comprises cell storage, cell drug research and cell clinical transformation with cell therapy as its core business.

Gracell Biotechnologies (Shanghai) Co., Ltd., part of Gracell Biotechnologies, Inc., is a company headquartered in Shanghai, China, that operates a clinical-stage biopharmaceutical company which discovers and develops cellular therapeutics for the patients suffering with cancer. It was founded in 2017 by Wei Cao, who has been the CEO since the inception date.\nThe company says this about itself: Gracell Biotechnologies Co., Ltd. (\"Gracell\") is a clinical-stage biotechnology company, committed to developing highly efficacious and affordable cell and gene therapies for the treatment of cancer. Gracell is dedicated to resolving the remaining challenges in CAR-T, such as high production costs, lengthy manufacturing process, lack of off-the-shelf products, and inefficacy against solid tumors. Led by a group of world-class scientists, Gracell is advancing FasTCAR™ (overnight production and younger cell phenotype), TruUCAR™ (off-the-shelf), DualCAR and EnhancedCAR T cell therapies for leukemia, lymphoma, myeloma, and solid tumors.

Assistance Publique H��pitaux de Marseille is a private company headquartered in Marseille, France, specializing in general medical and surgical hospitals.

Beijing Beilai Biotechnology Co., Ltd., established on 2015-10-26, Business scope includes biotechnology development,technology transfer,technical consulting,Technical Services;Sales of daily necessities,cosmetic,Ι class medical device,Chemical Products,chemical reagent,plastic products,Glass product.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.

Shanghai Yulong Biotechnology Co., Ltd., established on 2002-05-27, Business scope includes medical devices,In vitro diagnostic reagents(see license)production and marketing,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Suntech Biotechnology Co., Ltd., established on 2012-11-20, Business scope includes technology development in the field of biotechnology(human stem cells,Except for genetic diagnosis and treatment technology),technical consulting,technology transfer,Technical services and other related supporting services,Business Management Consulting Services,Health Information Consultation(except for medical diagnosis),laboratory instrument,laboratory consumables,laboratory reagent(Does not include medical devices,medicine,Hazardous Chemicals,Veterinary reagents)Wholesale.(Commodities that do not involve state trade management,Commodities involving quota license management,Commodities managed by special regulations,Handle in accordance with relevant national regulations). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]